The aim of the study is to evaluate the results of cyanoacrylate embolization (CAE) of the great (GSV) and small (SSV) saphenous veins in patients with varicose veins (VVs) of the lower limbs. Material and methods. This is a prospective observational study that started in 2017 at the «Neftyanik» Medical unit, including patients with VVs (C2 and higher according to the CEAP) who underwent CAE of the GSV and/or SSV using VenaSeal system. Patients underwent clinical and ultrasound evaluation 1 week, 3, 6, 12 months after the surgery and then every year. Efficiency criteria are: technical success of treatment; absence of recanalization; length of the GSV stump; vein involution; absence of reflux in the trunk; absence of reflux at the SFJ (saphenofemoral junction); no need to remove tributaries; no need for re-intervention in the trunk; CEAP classification of chronic venous disease; severity of disease according to the VCSS. Safety criteria are the absence of adverse reactions (ARs). Results. In the period of 2017–2019 cyanoacrylate embolization (CAE) have been performed on 122 limbs in 92 patients with VVs: 46 women and 46 men aged from 28 to 69 years (mean age 45.3±10.3 years) with the CEAP class of C2 (47.6 %), C3 (35.2 %), C4 (16.4 %), and C5 (0.8 %). The GSV trunk (diameter of 4.5–18.0 mm; mean 9.0±2.5) was treated in 82 % and the SSV (3.7–13.0 mm; mean — 7.0±2.3) in 18 %. Technical success was achieved in all cases. The length of the GSV stump varied from 0 to 48 mm (mean — 19.0±9.7). Sclerotherapy for varicose tributaries during the first 3 months was performed in 55 legs (45.1 %). Patients were followed up for 1 week — 18 months (3 months on average). Additional sclerotherapy for varicose tributaries was required for 35 (28.7 %) limbs. Trunk recanalization >5 cm was found in 8 limbs (6.6 %) 3–12 months after intervention and required second CAE (n=1), laser ablation (n=1) or sclerotherapy (n=4). Other ARs that did not require re-intervention were represented with GSV trunk (n=8; 6.6 %) or tributary (n=5; 4.1 %) phlebitis, allergic reaction (n=4; 3.3 %), tension sensation (n=5; 4.1 %), glue propagation towards the SFJ (n=2; 1,6 %), glue propagation from the junction to femoral vein (n=2; 1,6 %), sensitivity disturbance (n=4; 3,3 %), puncture site hematoma (n=1; 0,8 %). Conclusion. CAE of saphenous veins is effective and associated with an acceptable incidence of non-severe AEs with low re-intervention rate.